Skip to main content

Table 4 Gastrointestinal Symptom Rating Scale Abdominal Distension Subscore

From: A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms

Visit

Gas Defense

Placebo

Day 0

Screen/Rand

3.38 ± 2.13 (29)

4.14 ± 1.43 (29)

Day 14

Mid-Study

1.83 ± 1.04 (29)

2.48 ± 1.38 (29)

Day 29

End-of-Study

1.66 ± 1.08 (29)

2.38 ± 1.21 (29)

Change from

Day 0 to Day 14

-1.55 ± 1.88 (29)

-1.66 ± 1.70 (29)

Change from

Day 0 to Day 29

-1.72 ± 2.02 (29)

-1.74 ± 1.68 (29)

  1. Values are expressed as mean ± standard deviation.
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us